首页> 外文期刊>Journal of the American College of Radiology: JACR >ACR Appropriateness Criteria Renal Cell Carcinoma Staging
【24h】

ACR Appropriateness Criteria Renal Cell Carcinoma Staging

机译:ACR适当性标准肾细胞癌分期

获取原文
获取原文并翻译 | 示例
           

摘要

Renal cell carcinoma accounts for 2%-3% of all visceral malignancies. Preoperative imaging can provide important staging and anatomic information to guide treatment decisions. Size of the primary tumor and degree of local invasion, such as involvement of perinephric fat or renal sinus fat, and tumor thrombus in renal veins and inferior vena cava are important detriments to local staging of primary tumor. Both kidneys are assessed for presence of other synchronous lesions. The ACR Appropriateness Criteria (R) are evidence-based guidelines for specific clinical conditions that are reviewed every three years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and application by the panel of a well established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.
机译:肾细胞癌占所有内脏恶性肿瘤的2%-3%。术前影像检查可提供重要的分期和解剖学信息,以指导治疗决策。原发肿瘤的大小和局部浸润程度,例如会阴脂肪或肾窦脂肪的累及以及肾静脉和下腔静脉中的肿瘤血栓,对原发肿瘤的局部分期有重要的损害。评估两个肾脏是否存在其他同步病变。 ACR适当性标准(R)是针对特定临床状况的循证指南,由多学科专家小组每三年审查一次。指南的制定和审查包括对来自同行评审期刊的最新医学文献进行广泛的分析,并由专家小组采用公认的共识方法(改进的Delphi)来评估成像和治疗程序的适当性。在证据不足或不确定的情况下,专家意见可用于推荐影像学或治疗方法。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号